Barrick Gold, Roivant Sciences, Owens & Minor to report earnings Monday

Investing.com

Summary:

Earnings season continues, with several notable companies set to release their financial results for the upcoming trading day....

Earnings season continues, with several notable companies set to release their financial results for the upcoming trading day. Leading the pack are mining giant Barrick Gold, biopharmaceutical company Roivant Sciences (NASDAQ:ROIV), and healthcare solutions provider Owens & Minor, among others. Investors and analysts alike are eagerly anticipating these reports to gauge the health of various sectors and individual company performances.

Earnings Before the Open:

• Barrick Gold Corp. (NYSE:B): EPS est. $0.4366, Revenue est. $3.73B

• Roivant Sciences (ROIV): EPS est. -$0.2463, Revenue est. $7.69M

• Owens & Minor Inc (OMI): EPS est. $0.2885, Revenue est. $2.73B

• Ballard Power Systems Inc (NASDAQ:BLDP): EPS est. -$0.0906, Revenue est. $18.69M

• Green Plains Rene (NASDAQ:GPRE): EPS est. -$0.3258, Revenue est. $610.22M

• Madison Square Garden (SPHR): EPS est. -$1.55, Revenue est. $286.59M

• United States Cellular Corp (NYSE:USM): EPS est. $0.295, Revenue est. $907.63M

• Telos Corp (NASDAQ:TLS): EPS est. -$0.0659, Revenue est. $33.43M

• Telephone and Data Systems Inc (NYSE:TDS): EPS est. $0.0066, Revenue est. $1.17B

• Motorcar Parts of America (NASDAQ:MPAA): EPS est. $0.31, Revenue est. $180.1M

• CEVA (NASDAQ:CEVA): EPS est. $0.06, Revenue est. $25.98M

• I.D. Systems (NASDAQ:AIOT): EPS est. -$0.005, Revenue est. $104.5M

• Perion Network (NASDAQ:PERI): EPS est. $0.1725, Revenue est. $91.13M

• EuroDry (NASDAQ:EDRY): EPS est. -$0.865, Revenue est. $13.25M

• Excelerate Energy (EE): EPS est. $0.2945, Revenue est. $243.2M

• AAON (NASDAQ:AAON): EPS est. $0.3433, Revenue est. $326.15M

• Lincoln Education (NASDAQ:LINC): EPS est. $0.03, Revenue est. $113.96M

• Kymera Therapeutics Inc (NASDAQ:KYMR): EPS est. -$0.8325, Revenue est. $20M

• Dole (DOLE): EPS est. $0.5108, Revenue est. $2.16B

• Harvard Bioscienc (NASDAQ:HBIO): EPS est. -$0.005, Revenue est. $21.4M

• WideOpenWest Inc (NYSE:WOW): EPS est. -$0.175, Revenue est. $143.62M

• Legend Biotech Corp (LEGN): EPS est. -$0.1153, Revenue est. $234.23M

• Village Farms O (NASDAQ:VFF): EPS est. -$0.0152, Revenue est. $76.07M

• L.B. Foster Compa (NASDAQ:FSTR): EPS est. $0.59, Revenue est. $146.79M

• K92 Mining Inc (TSX:KNT) OTC (KNTNF): EPS est. $0.1488, Revenue est. $93.65M

• Franco Nev Corp (NYSE:FNV): EPS est. $1.13, Revenue est. $375.91M

• Rumble (RUM): EPS est. -$0.09, Revenue est. $25.05M

• Sonida Senior Living (SNDA): EPS est. -$0.63, Revenue est. None

• WW International (OTC:WGHTQ) (WW): EPS est. $0.20, Revenue est. None

Earnings After the Close:

• Fluence Energy (FLNC): EPS est. -$0.0104, Revenue est. $769.45M

• Apollo Investment (NASDAQ:MFIC): EPS est. $0.3768, Revenue est. $81.74M

• Plug Power (NASDAQ:PLUG): EPS est. -$0.1555, Revenue est. $158.48M

• CC Neuberger Principal Holdings II (GETY): EPS est. $0.0593, Revenue est. $234.5M

• Aquestive Therapeutics (NASDAQ:AQST): EPS est. -$0.1667, Revenue est. $11.32M

• GoPro Inc (NASDAQ:GPRO): EPS est. -$0.0667, Revenue est. $146.15M

• Celanese (NYSE:CE): EPS est. $1.4, Revenue est. $2.5B

• Amc Entertat Hld (NYSE:AMC): EPS est. -$0.0922, Revenue est. $1.31B

• Maravai Lifesciences Holdings Inc (MRVI): EPS est. -$0.0728, Revenue est. $47.61M

• Bally’s (BALY): EPS est. -$0.3908, Revenue est. $627.93M

• LivePerson (NASDAQ:LPSN): EPS est. -$0.1925, Revenue est. $61.63M

• Pubmatic Inc (PUBM): EPS est. -$0.1584, Revenue est. $67.84M

• Imprimis Pharmaceuticals Inc (NASDAQ:HROW): EPS est. $0.0072, Revenue est. $66M

• RumbleON Inc (NASDAQ:RMBL): EPS est. $0.0067, Revenue est. $307.29M

• Gevo (NASDAQ:GEVO): EPS est. -$0.0696, Revenue est. $39.55M

• Belite Bio ADR (BLTE): EPS est. -$0.388, Revenue est. $0.00

• Hallador Energy C (NASDAQ:HNRG): EPS est. -$0.17, Revenue est. $94.05M

• FinTech Acquisition Corp II (NASDAQ:IMXI): EPS est. $0.5011, Revenue est. $164.54M

• Xenon Pharmaceuticals (NASDAQ:XENE): EPS est. -$0.9873, Revenue est. $0.00

• Babcock & Wilcox Enterprises (BW): EPS est. -$0.0733, Revenue est. $182.07M

• Thunder Bridge A (NASDAQ:RPAY): EPS est. $0.1996, Revenue est. $73.57M

• Viant Technology (DSP): EPS est. $0.0078, Revenue est. $47.86M

• Green Dot Corp (NYSE:GDOT): EPS est. $0.299, Revenue est. $460.86M

• PennantPark Floating Rate Capital (NYSE:PFLT): EPS est. $0.2931, Revenue est. $66.04M

• Macerich Co (NYSE:MAC): EPS est. -$0.0788, Revenue est. $227.14M

• Rice Acquisition II (NPWR): EPS est. -$0.1156, Revenue est. $0.00

• Alcobra Ltd (NASDAQ:ARCT): EPS est. $3.21, Revenue est. $191.77M

• GrowGeneration (NASDAQ:GRWG): EPS est. -$0.1002, Revenue est. $40.95M

• ACV Auctions (ACVA): EPS est. $0.0771, Revenue est. $196.12M

• Meridianlink (MLNK): EPS est. $0.0956, Revenue est. $81.54M

• 3D Systems Corporation (NYSE:DDD): EPS est. -$0.1125, Revenue est. $103.92M

• PennantPark Investment Corp (NYSE:PNNT): EPS est. $0.18, Revenue est. $29.81M

• Tela Bio Inc (NASDAQ:TELA): EPS est. -$0.176, Revenue est. $20.67M

• Mercury Computer (NASDAQ:MRCY): EPS est. $0.2206, Revenue est. $243.61M

• Natural Gas Services Group Inc (NYSE:NGS): EPS est. $0.2567, Revenue est. $41.87M

• Archer Aviation (ACHR): EPS est. -$0.2514, Revenue est. $2.67M

• Ziprecruiter (ZIP): EPS est. -$0.1311, Revenue est. $111.74M

• Depomed (NASDAQ:ASRT): EPS est. -$0.076, Revenue est. $27.87M

• Hillenbrand Inc (NYSE:HI): EPS est. $0.495, Revenue est. $572.48M

• Quest Resou (NASDAQ:QRHC): EPS est. $0.05, Revenue est. $72.56M

• Enanta Pharmaceuticals Inc (NASDAQ:ENTA): EPS est. -$0.8403, Revenue est. $16.17M

• Aris Water Solutions (ARIS): EPS est. $0.3062, Revenue est. $120.76M

• Prime Acquisition (HPK): EPS est. $0.1075, Revenue est. $215.34M

• Cannae (NYSE:CNNE): EPS est. -$0.27, Revenue est. $111.1M

• GigCapital4 (BBAI): EPS est. -$0.0633, Revenue est. $41.19M

• Myomo Inc (NYSE:MYO): EPS est. -$0.098, Revenue est. $9.17M

• New Providence Acquisition Corp N (ASTS): EPS est. -$0.2133, Revenue est. $5.56M

• Fluidigm Corp (NASDAQ:LAB): EPS est. -$0.0667, Revenue est. $39.83M

• iHeartMedia A (NASDAQ:IHRT): EPS est. -$0.245, Revenue est. $912.35M

• Virtra Systems Inc (NASDAQ:VTSI): EPS est. -$0.05, Revenue est. $5.79M

• Apt Inv Manage (NYSE:AIV): EPS est. -$0.11, Revenue est. $54.62M

• Proficient Auto Logistics (PAL): EPS est. $0.34, Revenue est. None

• Kayne Anderson BDC (KBDC): EPS est. $0.44, Revenue est. None

• Quipt Home Medical NAQ (QIPT): EPS est. -$0.0357, Revenue est. $59.35M

• Compass Minerals Intl Inc (NYSE:CMP): EPS est. -$0.01, Revenue est. $207.61M

• AltC Acquisition (OKLO): EPS est. -$0.1171, Revenue est. $0.00

• Sabesp (NYSE:SBS): EPS est. $0.2946, Revenue est. $1.2B

• Gaiam (NASDAQ:GAIA): EPS est. -$0.07, Revenue est. $24.43M

• Yalla Group Ltd (NYSE:YALA): EPS est. $, Revenue est. $84.95M

• FGI Industries (FGI): EPS est. -$0.03, Revenue est. $33.46M

• ADA-ES (NASDAQ:ARQ): EPS est. -$0.0295, Revenue est. $26.61M

• Exodus Movement (EXOD): EPS est. $0.472, Revenue est. $31.5M

• Atlantic Acquisition (HFFG): EPS est. $0.025, Revenue est. $309.39M

• null Natural Resources Inc (INR): EPS est. $0.56, Revenue est. None

• TAT Technologies (TATT): EPS est. $0.29, Revenue est. $44.13M

• Inflection Point Acquisition II (USAR): EPS est. -$0.06, Revenue est. None

• Guardian Pharmacy Services (GRDN): EPS est. $, Revenue est. None

• MGO Global (HMR): EPS est. $, Revenue est. None

• Ralliant (RAL): EPS est. $, Revenue est. None

Be sure to check back daily for updates and insights into the earnings season and real-time results here and here. Do you want to trade the earnings of the biggest companies like a pro? Then get InvestingPro now and access over 1000 metrics that will give you a significant advantage in the shark tank that is Wall Street. Click here.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Risk Warnings and Disclaimers

You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.

Add to Favorites

VirTra Stock Set to Release Q2 Earnings: What's in Store?

Zacks

VirTra Inc. (VTSI) is set to release second-quarter 2025 results on Aug. 11, 2025, after market close.

The company delivered a trailing four-quarter average earnings surprise of 198.93%.

Let’s discuss the factors that are likely to be reflected in the upcoming quarterly results.

Factors to Note Ahead of VTSI’s Q2 Earnings

Revenues earned from higher sales of simulators and accessories, along with design & prototyping, can be expected to have boosted VTSI’s second-quarter top-line performance.

VirTra, Inc. Price and EPS Surprise

VirTra, Inc. price-eps-surprise | VirTra, Inc. Quote

Also, the successful delivery of the company’s V-XR extended reality platform, anticipated in the April-June 2025 quarter, is likely to have contributed favorably to its quarterly revenues.

In addition, VirTra’s steady use of AI tools to accelerate content development must have enabled it to generate higher volumes of certified training faster than ever before, thereby attracting more customers and bolstering its operational results.

However, slower bookings witnessed by the company in recent quarters, due to delays in federal budget disbursements and a more cautious demand environment across the law enforcement and defense sectors, might have hurt both revenues and earnings in the soon-to-be-reported quarter.

On the cost side, VTSI can be expected to have witnessed a decrease in cost of sales, caused by greater operational efficiencies, along with reduced operating expenses, thanks to its efforts to lower overhead costs. This, along with solid revenue growth expectations, must have contributed favorably to its second-quarter bottom line.

However, ongoing IVAS program development and initial V-XR production runs might have added upfront costs, weighing on its profitability and thereby earnings.

Q2 Expectations for VTSI

The Zacks Consensus Estimate for revenues is pegged at $6.38 million, indicating a 5.1% rise from the year-ago quarter’s reported figure.

The Zacks Consensus Estimate for earnings is pegged at 3 cents per share, which indicates a decline of 72.7% from the prior-year reported figure.

What the Zacks Model Unveils for VTSI

Our proven model does not conclusively predict an earnings beat for VirTra this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here, as you will see below.

Earnings ESP: VTSI has an Earnings ESP of 0.00%. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.

Zacks Rank: Currently, VirTra carries a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here.

Stocks to Consider

Below, we have mentioned players from the same sector that have the right combination of elements to beat on earnings this reporting cycle.

Archer Aviation (ACHR) is set to report second-quarter 2025 earnings on Aug. 11, 2025, after market close. It has an Earnings ESP of +2.70% and a Zacks Rank of 3 at present.

The Zacks Consensus Estimate for ACHR’s earnings is pegged at a loss of 19 cents per share, indicating a year-over-year improvement from a loss of 24 cents.

Heico Corp. (HEI) is set to report fiscal third-quarter 2025 results soon. It has an Earnings ESP of +1.16% and a Zacks Rank of 2 at present.

The Zacks Consensus Estimate for HEI’s earnings is pegged at $1.12 per share, indicating year-over-year growth of 15.5%. The consensus estimate for sales is pegged at $1.1 billion, indicating year-over-year growth of 12.2%.

CAE (CAE) is set to report fiscal first-quarter 2026 results on Aug. 13, 2025, before market open. It has an Earnings ESP of +0.46% and a Zacks Rank of 3 at present.

The Zacks Consensus Estimate for CAE’s earnings is pegged at 15 cents per share. The consensus estimate for sales is pegged at $810.1 million, indicating year-over-year growth of 3.4%.

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Risk Warnings and Disclaimers

Add to Favorites

Should You Buy, Hold, or Sell Archer Aviation Stock Ahead of Q2 Earnings?

Zacks

Archer Aviation Inc. (ACHR) is slated to report second-quarter 2025 results on Aug. 11, 2025, after market close.

The Zacks Consensus Estimate for earnings is pegged at a loss of 19 cents per share, suggesting an improvement from a loss of 24 cents in the prior-year quarter. The bottom-line estimate has improved over the past 60 days.

Archer Aviation’s earnings beat the Zacks Consensus Estimate in two of the trailing four quarters, met once and missed in the other, the average negative surprise being 10.86%.

Earnings Whispers

Our proven model predicts an earnings beat for ACHR this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat, which is the case here. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.

Archer Aviation has a Zacks Rank #3 and an Earnings ESP of +2.70%. You can see the complete list of today’s Zacks #1 Rank stocks here.

Key Factors to Consider Ahead of ACHR’s Q2 Earnings Release

In June 2025, Archer Aviation announced a strategic partnership with Jetex, a global aviation services provider, to develop infrastructure across Jetex’s 40 private terminals in over 30 countries, starting with the UAE. The collaboration builds on Archer’s existing infrastructure partnerships, aiming to expand a global vertiport network to support its planned commercial air taxi operations and future international growth. In June, Archer Aviation also signed an agreement with PT. IKN to deploy an initial fleet of Midnight aircraft in Indonesia, making it the third country where it plans to deploy Midnight under its “Launch Edition” program.

Such strategic agreements might have contributed favorably to ACHR’s second-quarter performance.

With the company continuing to invest in its engineering, manufacturing and commercial activities for the Midnight aircraft, it is likely to have incurred notable expenses for the program’s development. This, along with an increase in labor and materials spent due to its planned ramp of manufacturing activity for the Midnight aircraft, is likely to have increased Archer Aviation’s operating expenses, thereby weighing on its quarterly earnings performance.

However, ACHR’s technological advancement over the past few quarters while developing the Midnight jet is likely to have provided it with operational efficiency, aiding its quarterly bottom line.

The company’s quarterly results are also likely to reflect a strong cash balance account, particularly driven by the proceeds from its equity raise worth $850 million, following the White House’s announcement of an Executive Order by President Trump to implement an eVTOL Integration Pilot Program in the United States in June. This, in turn, must have brought its total liquidity position to approximately $2 billion, which should be duly reflected in its second-quarter balance sheet on Aug. 11.

Price Performance & Valuation

ACHR’s shares recently exhibited a downward trend, having lost a notable percentage in the past six months. Specifically, the stock fell 3.9% in the said period, underperforming the Zacks aerospace-defense industry’s gain of 19.7%. It also lagged the broader Zacks Aerospace sector’s return of 19.9% as well as the S&P 500’s rise of 4.4%.

Other notable stocks from the same industry have, however, gained in the past six months. Shares of Embraer (ERJ) and Boeing (BA) have rallied 37.8% and 25.9%, respectively, over the past year.

In terms of valuation, ACHR’s trailing price/book (P/B) ratio of 5.32 represents a discount to the industry average of 6.22.

Investment Thesis

ACHR offers promising near-term prospects, but whether its business will be sustainable in the long run remains uncertain. This is because the eVTOL aircraft market is still in its early stages, and ACHR's success depends not only on its ability to design, develop and certify eVTOL aircraft but also on how the demand for these vehicles evolves.

Public acceptance of eVTOLs as an alternative to traditional transport methods could face hurdles related to safety, noise and affordability concerns. Without widespread recognition, ACHR's growth potential may be constrained.

Additionally, ACHR and other aerospace manufacturers like BA and ERJ are navigating industry challenges, including persistent supply-chain disruptions and a shortage of skilled labor. Such factors could hinder ACHR’s ability to complete its projects on time.

Moreover, a quick glance at the company’s return on equity (ROE) over the past year compared to that of its industry reveals a dismal scenario. ACHR’s negative ROE indicates that it is incurring a loss, as evident from its recent quarterly results.

Should You Buy ACHR Before Aug. 11?

To conclude, ACHR is less likely to disappoint with its second-quarter results, considering its favorable Zacks Rank, positive Earnings ESP as well as improvement in its bottom-line estimate over the past 60 days. However, investors interested in this stock may consider staying on the sidelines before Monday, taking into account its poor ROE, dismal performance at the bourses as well as industry challenges.

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Risk Warnings and Disclaimers

Add to Favorites